232 related articles for article (PubMed ID: 37814323)
21. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
[TBL] [Abstract][Full Text] [Related]
22. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.
Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A
Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953
[TBL] [Abstract][Full Text] [Related]
23.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
24.
Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
[TBL] [Abstract][Full Text] [Related]
25. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.
Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA
mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376
[TBL] [Abstract][Full Text] [Related]
27. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
28. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
29. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
[TBL] [Abstract][Full Text] [Related]
30. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
31. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
32. Iron accelerates Fusobacterium nucleatum-induced CCL8 expression in macrophages and is associated with colorectal cancer progression.
Yamane T; Kanamori Y; Sawayama H; Yano H; Nita A; Ohta Y; Hinokuma H; Maeda A; Iwai A; Matsumoto T; Shimoda M; Niimura M; Usuki S; Yasuda-Yoshihara N; Niwa M; Baba Y; Ishimoto T; Komohara Y; Sawa T; Hirayama T; Baba H; Moroishi T
JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36136589
[TBL] [Abstract][Full Text] [Related]
33. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
34. Fabrication of hyaluronic acid-inulin coated Enterococcus faecium for colon-targeted delivery to fight Fusobacterium nucleatum.
Zhu P; Meng L; Shu Y; Xu Y; Liu W; Bi Y; Xu J; Meng L; Li Y
Carbohydr Polym; 2024 Apr; 329():121797. PubMed ID: 38286561
[TBL] [Abstract][Full Text] [Related]
35. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Kumar A; Thotakura PL; Tiwary BK; Krishna R
BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
[TBL] [Abstract][Full Text] [Related]
36. Fusobacterium nucleatum induces excess methyltransferase-like 3-mediated microRNA-4717-3p maturation to promote colorectal cancer cell proliferation.
Xu Q; Lu X; Li J; Feng Y; Tang J; Zhang T; Mao Y; Lan Y; Luo H; Zeng L; Xiang Y; Hu L; Zhang Y; Li Q; Deng L; He X; Tang B; Mao X; Zeng D
Cancer Sci; 2022 Nov; 113(11):3787-3800. PubMed ID: 35984699
[TBL] [Abstract][Full Text] [Related]
37. Profiling Fusobacterium infection at high taxonomic resolution reveals lineage-specific correlations in colorectal cancer.
Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Cai C; Wei Q; Qin H
Nat Commun; 2022 Jun; 13(1):3336. PubMed ID: 35680952
[TBL] [Abstract][Full Text] [Related]
38.
Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
Front Immunol; 2021; 12():658681. PubMed ID: 34093546
[No Abstract] [Full Text] [Related]
39. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
40. Clinical Significance of
Zhang N; Liu Y; Yang H; Liang M; Wang X; Wang M; Kong J; Yuan X; Zhou F
Pathol Oncol Res; 2021; 27():1609846. PubMed ID: 34305476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
